Trial intelligence / Profile preview

Hepatitis B Vaccination Through Syringe Exchange Programs

NCT01259453Phase 4Completed

Sponsor
Yale University
Start
May 2003
Primary completion
Aug 2006
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by Yale University. Started May 2003; status: completed.

02

Drugs

hepatitis b vaccine recombinant
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT01259453.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01259453.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call